Skip to main content
Fig. 7 | BMC Genomic Data

Fig. 7

From: Identification of immune-related molecular markers in intracranial aneurysm (IA) based on machine learning and cytoscape-cytohubba plug-in

Fig. 7

Expression analysis of key DEmRNAs in UIA, RIA and normal control groups. A: Expression analysis of NRXN1 in UIA, RIA and normal control groups; B: Expression analysis of GRIA2 in UIA, RIA and normal control groups; C: Expression analysis of SLC1A2 in UIA, RIA and normal control groups; D: Expression analysis of SLC17A7 in UIA, RIA and normal control groups; E: Expression analysis of IL6 in UIA, RIA and normal control groups; F: Expression analysis of VEGFA in UIA, RIA and normal control groups; G: Expression analysis of SYP in UIA, RIA and normal control groups. The Wilcoxon test was used to statistically analyze the expression difference of key DEmRNAs expression between UIA, RIA and normal control groups. * represents P < 0.05; ** represents P < 0.01; *** represents P < 0.001; **** represents P < 0.0001; ns represents no significant difference. P < 0.05 was considered statistically significant

Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us